According to a gazette notification of the draft rules published on June 5, a hospital or medical institution may import new drug for “compassionate use for treatment of patients suffering from life threatening disease or disease causing serious permanent disability or disease requiring therapy for unmet medical need”, which has not been permitted in the country, but under Phase-III clinical trial (human trial) in the country or abroad, by making an application to the Central Drug Regulator.

To reduce the case fatality rate, the officials were briefed on measures that include prioritising high-risk and vulnerable segments like elderly people and people with comorbidities while contact-tracing to prevent deaths.

“If community transmission is ascertained at the meeting tomorrow, we will have to change our strategy accordingly,” Deputy Chief Minister Manish Sisodia said